S&P 500 Healthcare Sector SPDR (XLV)

Cardinal Health has surpassed the broader healthcare sector’s performance over the past year, and analysts are expressing continued confidence in its growth potential.

As Moderna has underperformed its broader sector recently, analysts remain cautious about the stock’s prospects.

Becton, Dickinson and Company has lagged behind the broader healthcare sector recently, yet Wall Street analysts remain highly optimistic about its future growth potential.

The U.S. economy added 151,000 jobs in February 2025, better than the downwardly revised 125,000 in January but less than the 170,000-consensus forecast. The U.S. unemployment rate rose to 4.1% in February...

President Trump's reciprocal tariffs have weakened U.S. consumer and business sentiment, as consumers grow uncertain about the 'chaotic' U.S. policy, according to Reuters.Global growth concerns have resurfaced...

Boston Scientific has recently outpaced the broader healthcare sector, with analysts maintaining a highly bullish outlook on its future performance.

Amgen has outperformed the healthcare sector over the past year, and analysts are moderately optimistic about the stock’s prospects.

AbbVie has outperformed the healthcare sector over the past year, and analysts are moderately optimistic about the stock’s prospects.

Despite its notable underperformance compared to other healthcare stocks over the past year, analysts remain strongly bullish on UnitedHealth Group’s prospects.

The stock fell over 7% on Thursday after reports that federal health officials under the Trump administration are re-evaluating Moderna's $590 million contract for bird flu vaccine development.